All California public payers now cover Monogram's Trofile assay
SOUTH SAN FRANCISCO, Calif., March 17 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that the California Medicaid program (Medi-Cal) has established coverage and reimbursement for Monogram's Trofile Assay.
Medi-Cal is the state medical assistance program in California established to provide essential medical care and services to individuals or families on public assistance, or whose income is not sufficient to meet their individual needs.
"We are delighted that Medi-Cal has established coverage for Trofile," said Bill Welch, Monogram chief commercial officer. "California has the second largest population of HIV/AIDS patients in the U.S. and now all public payers in the state provide coverage for Trofile. With coverage now clarified, we expect that testing activity for Medi-Cal beneficiaries may increase."
Previously, the California ADAP Program (in November 2007), and the federal Medicare Program (in September 2007) established coverage for Trofile. The AIDS Drug Assistance Program, or "ADAP", is a state and federally funded program, administered separately in each state to provide healthcare coverage for HIV/AIDS patients without other coverage. Throughout the U.S. 33 state ADAP/Ryan White entitlement state programs now have coverage established for Trofile.
Trofile is now a covered benefit with 24 state Medicaid programs,
including California, Florida, Illinois, Maryland, Massachusetts, Michigan,
New Jersey, Ohio, Texas and Wisconsin. In addition, Trofile is a covered
benefit by Medicare, the Veteran's Administration, the Corrections and
Prison Systems and Department of Indian Affairs, as well as with
|SOURCE Monogram Biosciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved